US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Tuesday that its board of directors has declared a dividend of USD2.52 per share for the fourth quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
The Q4 dividend will be paid on 11 December 2026, to all stockholders of record as of the close of business on 20 November 2026.
AbbVie declares quarterly dividend of USD1.73 per share
Alvotech and Lotus agree licensing deal for two biosimilar candidates
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
BSF secures exclusive global commercialisation partnership for ETSYL
Saniona grants AstronauTx worldwide rights to neurological disease programme
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones